Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Emeritus Professor

Barry L Reed is Emeritus Professor within the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University. Following his retirement in 2006 after 43 years of dedicated service, the faculty established the annual Professor Barry L. Reed Distinguished Lecture in recognition of his outstanding contributions to the faculty, Monash University and the pharmacy profession.

After receiving his PhC in 1962, Barry received a Fellowship of the Pharmaceutical Society by thesis in 1966 and a Bachelor of Pharmacy in 1968 from the Victorian College of Pharmacy. He then entered the Intersearch PhD program at the University of Kansas and was awarded a PhD in 1975. Rising through the academic ranks at the college, Barry was appointed M.A. Nicholas Industrial Professor of Biopharmaceutics and Associate Director of the Institute of Drug Technology (IDT) in 1978. He was appointed Professor of Biopharmaceutics in 1990, some years before the Victorian College of Pharmacy amalgamated with Monash University.

Barry has made many significant contributions to the profession of pharmacy. He has served on the Medicines Evaluation Committee since its inception and the Proprietary Medicines Advisory Committee since 1984. He was a member of the Australian Pharmacy Examining Council from 1993 to 2002 and the Australian Pharmacy Council until 2008. He was President of the Pharmacy Board of Victoria for eleven years and a member of the Board from 1986-2008.

As an academic researcher, Barry was the first scientist at the college to receive grants from the Australian Research Grants Committee (ARGC) and the Anti-Cancer Council and his research subsequently attracted substantial funding from Nicholas Kiwi and Acrux. He has authored over 100 scientific papers and patents, and numerous conference abstracts and presentations.

Barry has mentored a large number of postgraduate students and research staff during his career, and many of his former students have excelled within the pharmaceutical industry and academia. His research led him to co-found Acrux, a company established to commercialise the 'spray-on' drug delivery technology that he discovered and developed together with Dr Tim Morgan and Dr Barrie Finnin. The metered dose transdermal spray technology has led to one product being launched in the USA (EvamistTM), with other products in late stage clinical development for eventual marketing in the USA and internationally.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being